FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval
(Adnkronos) – CHICAGO, March 7, 2023 /PRNewswire/ — Neuromod Devices Ltd. announced today that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire, the first bimodal neuromodulation
